Top Biotechnology & Medical Research stocks in Australasia

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Market Cap
Price to Earnings
Dividend Yield
au flag iconTLXTelix PharmaceuticalsAU$6.46bn1125.92n/a
au flag iconCU6Clarity PharmaceuticalsAU$1.66bnn/an/a
au flag iconMSBMesoblastAU$1.18bnn/an/a
au flag iconPYCPYC TherapeuticsAU$485.27mn/an/a
au flag iconOPTOptheaAU$458.32mn/an/a
au flag iconIMUImugeneAU$408.64mn/an/a
au flag iconIMMImmutepAU$404.20mn/an/a
au flag iconRACRace OncologyAU$317.18mn/an/a
au flag iconDXBDimerixAU$202.43mn/an/a
au flag iconCGSCogstateAU$198.79m26.57n/a
au flag iconACWActinogen MedicalAU$176.23mn/an/a
au flag iconALAArovella TherapeuticsAU$138.72mn/an/a
au flag iconPIQProteomics International LaboratoriesAU$116.83mn/an/a
au flag iconLTPLtr PharmaAU$108.75mn/an/a
au flag iconPARParadigm BiopharmaceuticalsAU$105.45mn/an/a
au flag iconAGNArgenica TherapeuticsAU$89.24mn/an/a
au flag iconPERPercheron TherapeuticsAU$72.12mn/an/a
au flag iconNTINeurotech InternationalAU$70.45mn/an/a
nz flag iconPEBPacific EdgeNZ$68.15mn/an/a
au flag iconIIQInoviqAU$52.91mn/an/a